Market Access News | pharmaphorum

News

Novo Nordisk claims first GLP-1 approval in MASH

Under pressure from rivals in the GLP-1 space, Novo Nordisk has been given a leg-up with a first-in-class approval for Wegovy in liver disease MASH.

News

RFK Jr revives childhood vaccine task force

HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.

News

FDA clears Precigen's rare tumour immunotherapy

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis, Papzimeos, its first product.

News

Trump orders stockpiling of essential medicine ingredients

Trump has ordered the creation of a six-month stockpile of ingredients to make essential medicines, in another part of his push to reshore production.

News

Under pressure from Trump, Lilly hikes Mounjaro prices in UK

Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro to bring it into parity with other European markets.

News

NHS cleared to use AZ's Fasenra for rare autoimmune disease

NICE backs NHS use of an AstraZeneca drug for one rare disease, but says it can't recommend a BioMarin therapy for another.

Novo Nordisk claims first GLP-1 approval in MASH

RFK Jr revives childhood vaccine task force

FDA clears Precigen's rare tumour immunotherapy

Trump orders stockpiling of essential medicine ingredients

Under pressure from Trump, Lilly hikes Mounjaro prices in UK

NHS cleared to use AZ's Fasenra for rare autoimmune disease

Pharvaris plans filings for HAE drug after pivotal trial win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks